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Introduction {#sec005}
============

Influenza is an acute self-limiting viral disease which, in the majority of cases, is inconvenient but generally not serious. However, seasonal influenza can cause severe illness, hospitalisations and deaths, especially in those who are at 'high risk' due to age or underlying chronic health problems.

There are three types of influenza virus, Type A, Type B and Type C \[[@pone.0134928.ref001]\]; only A and B cause significant disease in humans \[[@pone.0134928.ref002]\]. Influenza A, of which there are currently two subtypes circulating, H1N1 and H3N2 \[[@pone.0134928.ref003]\], is responsible for seasonal epidemic and occasional pandemic activity. Influenza B, which currently has two antigenically distinct lineages, Yamagata and Victoria, is responsible for outbreaks particularly in institutional settings.

Influenza can be prevented by vaccination. Annual vaccination against seasonal influenza is recommended for high-risk groups, including people aged 65 years or more and people with chronic health conditions \[[@pone.0134928.ref004]\], and the United Kingdom (UK) recently extended vaccination recommendations to include children \[[@pone.0134928.ref005],[@pone.0134928.ref006]\].

Although several studies have previously estimated the burden of illness attributable to influenza in the UK \[[@pone.0134928.ref007]--[@pone.0134928.ref009]\], they have some limitations. For example, one did not include hospital data and thus is expected to have underestimated the burden of influenza \[[@pone.0134928.ref007]\], and others did not link hospital and general practice databases \[[@pone.0134928.ref008],[@pone.0134928.ref009]\] or collect vaccination and risk status \[[@pone.0134928.ref008]\]. There is considerable disparity in estimates of influenza mortality derived from previous studies \[[@pone.0134928.ref010]\]. Furthermore, data are lacking on the burden of illness stratified by risk status, complication status (with or without complications of influenza recorded) or vaccination status. A recent review of cost-of-illness studies in influenza worldwide identified no UK studies reporting national cost-of-illness estimates, and only a few studies on the cost of influenza in specific population groups (children) \[[@pone.0134928.ref011]\]. Thus, although the burden of influenza in England has been shown to be substantial, accounting for 11,199 hospital admissions and 400 deaths annually in patients not in a clinical risk group, and 6,054 hospital admissions and 1,406 deaths annually in patients in a clinical risk group \[[@pone.0134928.ref009]\], it has not been described in sufficient detail.

To provide a more detailed understanding of the burden of influenza-like illness (ILI) to healthcare resources in the UK, we have conducted a large database analysis using linked hospital and general practice databases to quantify primary and secondary resource use and costs associated with ILI. To our knowledge, this is the first study to use linked hospital and general practice databases to assess the burden of illness in both primary and secondary care in ILI in the UK. The primary results of the study have been published elsewhere (Watkins et al., in preparation). The objective of the present analysis was to examine resource use and costs by vaccination and risk status.

Materials and Methods {#sec006}
=====================

This was a retrospective, cross-sectional, observational study using data extracted from UK databases for the period 21 January 2001 to 31 March 2009 inclusive. The study period ended immediately before the 2009 H1N1 influenza pandemic. The data were divided into influenza seasons running from 1 April to 31 March inclusive, e.g. 1 April 2001 to 31 March 2002, etc. The study thus covered nine influenza seasons. The first season (2000--2001) ran from the study start date on 1 January 2001 to 31 March 2001. Influenza circulated from week 4 in 2001 according to surveillance data from the Health Protection Agency (HPA), so the study would have captured the majority of the influenza cases in the 2000--2001 season, although it is possible that there were some cases in the last weeks of 2000 for which data were not collected.

Data collection {#sec007}
---------------

Influenza cases are generally not virologically confirmed in routine UK clinical practice \[[@pone.0134928.ref008]\], and influenza or ILI is rarely recorded specifically in medical notes \[[@pone.0134928.ref012]\]. Thus, neither a specific diagnosis of influenza/ILI nor virologically confirmed influenza could be used as the selection method. The General Practice Research Database (GPRD) codes general practitioner (GP) consultations using clinical READ codes. The proportion of patients in the GPRD with linked data in the Hospital Episode Statistics (HES) dataset is 58.8%, and the linked patients are representative of the whole GPRD population \[[@pone.0134928.ref013]\]. Since this study was initiated, the GPRD has changed its name and is now known as The Clinical Practice Research Datalink (CPRD).

Data on patients who had at least one GP consultation with a READ code describing influenza, acute upper or lower respiratory tract infection, or ILI were extracted from the linked GPRD-HES dataset for the period between 21^st^ January 2001 and 31^st^ March 2009 inclusive. Consultations coded with any of these READ codes that occurred during periods of peak influenza circulation were attributed to ILI ([S1 File](#pone.0134928.s001){ref-type="supplementary-material"}). Consultations coded with any of these specific READ codes that occurred during periods of peak influenza circulation were attributed to ILI. Peak influenza periods were those weeks when influenza A and influenza B were circulating, identified by regression analysis of surveillance data on circulating influenza and other respiratory pathogens obtained from the UK Health Protection Agency (HPA) for the period November 2002 to December 2008 \[[@pone.0134928.ref014]\], using the same technique as Pitman et al. \[[@pone.0134928.ref008]\] (described further below). Patients with GP consultations coded with a relevant READ code during these influenza periods were included in the study if they also had a minimum of 14 days observation before and after the index event; and at least 1 year observation before diagnosis.

Patients were stratified by age group (\<5 years; 5--18 years, 19--49 years, 50--64 years, 65+ years), by risk status (high-risk as defined by National Institute for Health and Care Excellence \[[@pone.0134928.ref015]\] or Department of Health \[[@pone.0134928.ref016]\] criteria, or low-risk) and by influenza vaccination status. Patients were categorised as 'vaccinated' if they had a record of an influenza vaccination in the same winter flu season as the index episode.

Data on GP consultations and hospital admissions were extracted from the linked GPRD and HES dataset ([S1 File](#pone.0134928.s001){ref-type="supplementary-material"}). If there were two GP consultations recorded for a patient on the same day, only one was counted. Data were observed for 14 days after the GP consultation to identify any hospital admission for influenza or complications following influenza. Only the first episode of each hospitalisation was retained in the dataset, as this was more likely to be related to the cause of the admission rather than to subsequent complications.

Mortality data were identified from the linked GPRD-HES dataset, where mortality was recorded by the GP or at hospital discharge. Population estimates were obtained from the Office for National Statistics (ONS), using mid-year estimates for the resident population for 2001--2009 \[[@pone.0134928.ref017]\].

Surveillance data on circulating influenza and other respiratory infections were obtained from the UK HPA for the period November 2002 to December 2008, which were grouped into flu weeks (periods of approximately 4--5 weeks). Data on the mismatch between the influenza vaccine and circulating influenza virus strains/lineages were obtained from the HPA \[[@pone.0134928.ref014]\].

Outcomes {#sec008}
--------

The primary outcome measures were mortality, resource use (only those GP consultations and hospital admissions with READ codes related to the episode were included) and cost associated with influenza in primary and secondary care, stratified by age group, complication status, vaccination status and risk status. This paper presents data on vaccination uptake, and resource use, cost and mortality by vaccination status and degree of mismatch. Other results of the study have been published elsewhere (Watkins et al., in preparation). Medications prescribed were limited to include items such as antipyretics, analgesics, antivirals, nasal decongestants, antihistamines and antibiotics. Furthermore, only those encounters related with an episode were included in the analysis any routine visits or unrelated encounters were excluded.

Cost data {#sec009}
---------

Unit costs for hospitalisations, GP consultations and outpatient visits were obtained from the Personal Social Services Research Unit database for 2011 \[[@pone.0134928.ref018]\]. Resource use data were combined with unit cost data to estimate total costs, from the perspective of the UK National Health Service. All costs were expressed in £ (pounds sterling) using 2011 costs.

Data analysis {#sec010}
-------------

Regression analysis was used to estimate the proportion of GP consultations, hospitalisations and deaths potentially attributable to each pathogen, using the same technique as Pitman et al. \[[@pone.0134928.ref008]\], previously described by Ryan et al \[[@pone.0134928.ref019]\].

The observed temporal trends in laboratory confirmed reports of agents that could potentially cause influenza/acute respiratory infection/ILI was compared with the number of events under consideration (GP consultations, hospital episodes, or mortality) over the same time period. The latter was used as the dependent variable of a multiple regression. The independent variables were the weekly number of national laboratory reports (HPA data, 2001--2009) for adenovirus, coronavirus, influenza A, influenza B, *Mycoplasma pneumoniae*, parainfluenza, respiratory syncytial virus, and rhinovirus. Laboratory reports were not age stratified as this would have resulted in too few individuals in certain classes.

This method of linear regression uses the number of laboratory reports for pathogen *i* in week *j*, *L* ~*ij*~ and a background number of national laboratory reports to estimate the regression coefficients *α* ~*j*~ that fit into the equation: *Y* ~*j*~ = *c + Σ* ~*i*~ *α* ~*i*~ *\* L* ~*ij*~, *Y* ~*j*~ indicating the independent variable (weekly number of national laboratory reports aggregated over all age groups). A multivariable regression, assuming normality of the error terms, was performed. The initial model included all the organisms as explanatory variables. The significance of each organism was assessed, and if the *p* value was \>0.1 or the variable was significant but the resulting coefficient negative (which is biologically implausible) the variable was discarded from the model. The validity of the final model was assessed in terms of the proportion of the variation it explained (R^2^), the significance of the joint relationship between the observed and independent variables in each model (i.e. the probability that R differed significantly from zero), and the impact of changes in the model specification.

Regression analysis was used to assess the relationship between burden and the degree of mismatch between the influenza vaccine and the circulating influenza virus strains in each year. Multivariate analysis was used to uncover structure within the data and those factors contributing to excess burden. This was based on knowledge of the source data once it has been obtained and processed. Generalised linear models were fitted to characterise any association between baseline characteristics and burden

Vaccinated and unvaccinated patients categorised as high-risk were compared using an independent samples t-test with age and number of risk conditions as the test variables. A similar analysis was undertaken in patients categorised as not high-risk, using age as the test variable.

To extrapolate from the database sample to the total UK population, a multiplying factor was calculated. The annual average total UK population during the study period was 60,313,633, using ONS mid-year estimates for the resident population for 2001--2009 \[[@pone.0134928.ref017]\]. The annual average number of patients in the linked GPRD-HES database population was 1,662,953 between 2000 and 2009, calculated from the GPRD-HES data extract. Dividing the database population by the total UK population gives a multiplying factor of 36.3. Results from the database were then multiplied by this factor to estimate the total burden in the whole of the UK. The same factor was used for all patient groups, as age-specific, complication-specific and risk-specific populations were not available. No adjustments for demographics were made.

Results {#sec011}
=======

Study population {#sec012}
----------------

The linked dataset included 156,193 patients with at least one GP consultation for ILI (defined as described in the Methods). The mean age was 42.7 years and 55% were women. The demographic characteristics of the study population have been published elsewhere (Watkins et al., in preparation). [Table 1](#pone.0134928.t001){ref-type="table"} shows the breakdown of general physician visit by READ code.

10.1371/journal.pone.0134928.t001

###### General Practitioner Visit Break down by READ Code.

![](pone.0134928.t001){#pone.0134928.t001g}

  READ Code   Count of patient visits   Description
  ----------- ------------------------- -------------------------------------------------------------
  H27z.11     125769                    Flu like illness
  H27..00     14359                     Influenza
  H2z..00     5789                      Pneumonia or influenza NOS
  16L..00     3809                      Influenza-like symptoms
  H27z.12     2050                      Influenza like illness
  H27z.00     1937                      Influenza NOS
  H2...00     1805                      Pneumonia and influenza
  H2y..00     203                       Other specified pneumonia or influenza
  H27y100     151                       Influenza with gastrointestinal tract involvement
  H271z00     101                       Influenza with respiratory manifestations NOS
  H270000     68                        Influenza with bronchopneumonia
  H271000     66                        Influenza with laryngitis
  H271100     31                        Influenza with pharyngitis
  H270.00     21                        Influenza with pneumonia
  H270.11     15                        Chest infection---influenza with pneumonia
  H270z00     11                        Influenza with pneumonia NOS
  H271.00     6                         Influenza with other respiratory manifestation
  F030800     1                         Encephalitis due to influenza-specific virus not identified
  H27y000     1                         Influenza with encephalopathy

Vaccination uptake {#sec013}
------------------

[Table 2](#pone.0134928.t002){ref-type="table"} shows the percentage of patients in each risk group vaccinated by year. Elderly patients (age 65+ years) had the highest uptake rates, and uptake rates generally increased between the beginning and end of the study period in each risk group.

10.1371/journal.pone.0134928.t002

###### Percentage of patients with a vaccination record each year, by risk group.

![](pone.0134928.t002){#pone.0134928.t002g}

  Year   All High Risk   Respiratory   Central Nervous System   Diabetes   Chronic Heart Disease   Liver Disease   Renal Disease   Compromised Immune System   Age 65+ years   Not high risk and aged \<65 years
  ------ --------------- ------------- ------------------------ ---------- ----------------------- --------------- --------------- --------------------------- --------------- -----------------------------------
  2001   43.6%           40.5%         40.7%                    55.7%      49.2%                   32.8%           54.8%           52.6%                       65.4%           14.3%
  2002   48.2%           43.1%         44.8%                    60.5%      52.2%                   35.3%           58.9%           55.8%                       70.9%           15.0%
  2003   51.5%           47.6%         48.4%                    67.3%      57.7%                   35.3%           65.3%           59.9%                       76.0%           15.3%
  2004   55.9%           51.1%         52.4%                    74.3%      61.1%                   40.0%           68.4%           67.1%                       79.4%           15.3%
  2005   61.4%           53.2%         54.5%                    80.5%      67.5%                   47.7%           72.6%           73.3%                       84.5%           17.4%
  2006   58.1%           64.7%         50.5%                    77.8%      64.7%                   50.0%           70.4%           66.4%                       81.3%           15.0%
  2007   59.1%           51.3%         54.2%                    80.2%      65.6%                   52.2%           72.3%           69.9%                       80.3%           14.8%
  2008   59.4%           51.6%         55.8%                    79.2%      65.7%                   53.7%           74.8%           71.3%                       78.4%           15.0%
  2009   61.2%           54.0%         56.0%                    80.2%      67.6%                   62.5%           77.6%           68.8%                       75.9%           18.3%

[Table 3](#pone.0134928.t003){ref-type="table"} shows the percentage of patients vaccinated each year by age and risk status. Overall, there were 21,518 high-risk patients, of whom 12,514 (58.2%) were vaccinated and 9,004 (41.8%) were not vaccinated. There were 134,675 low-risk patients of whom 17,482 (13.0%) were vaccinated and 117,193 (87.0%) were not vaccinated.

10.1371/journal.pone.0134928.t003

###### Vaccination status by age, risk group and year.
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  Influenza Year (April---March)                                   Non-vaccinated   Vaccinated           
  -------------------------------- ------------- -------- -------- ---------------- ------------ ------- -------
  2001                             Overall                18,591   14,903           80.2%        3,688   19.8%
  \<5 years                        Not At Risk   373      368      98.7%            5            1.3%    
                                   At Risk       30       29       96.7%            1            3.3%    
  5--18 years                      Not At Risk   2,095    2,065    98.6%            30           1.4%    
                                   At Risk       145      122      84.1%            23           15.9%   
  19--49 years                     Not At Risk   8,821    8,474    96.1%            347          3.9%    
                                   At Risk       651      481      73.9%            170          26.1%   
  50--64 years                     Not At Risk   2,887    2,352    81.5%            535          18.5%   
                                   At Risk       570      291      51.1%            279          48.9%   
  \>64 years                       Not At Risk   2,104    515      24.5%            1,589        75.5%   
                                   At Risk       915      206      22.5%            709          77.5%   
  2002                             Overall                16,110   13,384           83.1%        2,726   16.9%
  \<5 years                        Not At Risk   400      399      99.8%            1            0.3%    
                                   At Risk       25       25       100.0%           0            0.0%    
  5--18 years                      Not At Risk   1,973    1,952    98.9%            21           1.1%    
                                   At Risk       111      91       82.0%            20           18.0%   
  19--49 years                     Not At Risk   7,485    7,213    96.4%            272          3.6%    
                                   At Risk       578      423      73.2%            155          26.8%   
  50--64 years                     Not At Risk   2,658    2,291    86.2%            367          13.8%   
                                   At Risk       557      269      48.3%            288          51.7%   
  \<64 years                       Not At Risk   1,529    519      33.9%            1,010        66.1%   
  At Risk                          794           202      25.4%    592              74.6%                
  2003                             Overall                23,734   19,930           84.0%        3,804   16.0%
  \<5 years                        Not At Risk   675      674      99.9%            1            0.1%    
                                   At Risk       28       27       96.4%            1            3.6%    
  5--18 years                      Not At Risk   2,979    2,932    98.4%            47           1.6%    
                                   At Risk       157      128      81.5%            29           18.5%   
  19--49 years                     Not At Risk   10,909   10,568   96.9%            341          3.1%    
                                   At Risk       816      607      74.4%            209          25.6%   
  50--64 years                     Not At Risk   4,194    3,666    87.4%            528          12.6%   
                                   At Risk       779      404      51.9%            375          48.1%   
  \<64 years                       Not At Risk   2,029    672      33.1%            1,357        66.9%   
                                   At Risk       1,168    252      21.6%            916          78.4%   
  2004                             Overall                13,159   10,256           77.9%        2,903   22.1%
  \<5 years                        Not At Risk   193      192      99.5%            1            0.5%    
                                   At Risk       13       13       100.0%           0            0.0%    
  5--18 years                      Not At Risk   1,055    1,032    97.8%            23           2.2%    
                                   At Risk       51       36       70.6%            15           29.4%   
  19--49 years                     Not At Risk   6,070    5,817    95.8%            253          4.2%    
                                   At Risk       534      339      63.5%            195          36.5%   
  50--64 years                     Not At Risk   2,396    2,029    84.7%            367          15.3%   
                                   At Risk       529      210      39.7%            319          60.3%   
  \<64 years                       Not At Risk   1,414    391      27.7%            1,023        72.3%   
  At Risk                          904           197      21.8%    707              78.2%                
  2005                             Overall                20,905   16,678           79.8%        4,227   20.2%
  \<5 years                        Not At Risk   271      265      97.8%            6            2.2%    
                                   At Risk       8        8        100.0%           0            0.0%    
  5--18 years                      Not At Risk   1,948    1,910    98.0%            38           2.0%    
                                   At Risk       122      87       71.3%            35           28.7%   
  19--49 years                     Not At Risk   9,877    9,491    96.1%            386          3.9%    
                                   At Risk       818      530      64.8%            288          35.2%   
  50--64 years                     Not At Risk   3,843    3,289    85.6%            554          14.4%   
                                   At Risk       806      351      43.5%            455          56.5%   
  \<64 years                       Not At Risk   1,930    484      25.1%            1,446        74.9%   
                                   At Risk       1,282    263      20.5%            1,019        79.5%   
  2006                             Overall                18,015   14,299           79.4%        3,716   20.6%
  \<5 years                        Not At Risk   266      264      99.2%            2            0.8%    
                                   At Risk       5        5        100.0%           0            0.0%    
  5--18 years                      Not At Risk   2,520    2,453    97.3%            67           2.7%    
                                   At Risk       133      94       70.7%            39           29.3%   
  19--49 years                     Not At Risk   8,108    7,707    95.1%            401          4.9%    
                                   At Risk       634      397      62.6%            237          37.4%   
  50--64 years                     Not At Risk   3,085    2,587    83.9%            498          16.1%   
                                   At Risk       659      257      39.0%            402          61.0%   
  \<64 years                       Not At Risk   1,510    344      22.8%            1,166        77.2%   
  At Risk                          1,095         191      17.4%    904              82.6%                
  2007                             Overall                18,960   15,214           80.2%        3,746   19.8%
  \<5 years                        Not At Risk   224      222      99.1%            2            0.9%    
                                   At Risk       8        6        75.0%            2            25.0%   
  5--18 years                      Not At Risk   1,755    1,710    97.4%            45           2.6%    
                                   At Risk       89       60       67.4%            29           32.6%   
  19--49 years                     Not At Risk   9,257    8,912    96.3%            345          3.7%    
                                   At Risk       664      435      65.5%            229          34.5%   
  50--64 years                     Not At Risk   3,407    2,951    86.6%            456          13.4%   
                                   At Risk       762      315      41.3%            447          58.7%   
  \<64 years                       Not At Risk   1,454    354      24.3%            1,100        75.7%   
                                   At Risk       1,340    249      18.6%            1,091        81.4%   
  2008                             Overall                20,743   16,863           81.3%        3,880   18.7%
  \<5 years                        Not At Risk   244      243      99.6%            1            0.4%    
                                   At Risk       8        8        100.0%           0            0.0%    
  5--18 years                      Not At Risk   1,523    1,488    97.7%            35           2.3%    
                                   At Risk       66       43       65.2%            23           34.8%   
  19--49 years                     Not At Risk   10,223   9,870    96.5%            353          3.5%    
                                   At Risk       670      441      65.8%            229          34.2%   
  50--64 years                     Not At Risk   4,145    3,679    88.8%            466          11.2%   
                                   At Risk       783      342      43.7%            441          56.3%   
  \<64 years                       Not At Risk   1,752    478      27.3%            1,274        72.7%   
  At Risk                          1,329         271      20.4%    1,058            79.6%                
  2009                             Overall                5,976    4,670            78.1%        1,306   21.9%
  \<5 years                        Not At Risk   71       71       100.0%           0            0.0%    
                                   At Risk       3        3        100.0%           0            0.0%    
  5--18 years                      Not At Risk   497      486      97.8%            11           2.2%    
                                   At Risk       22       15       68.2%            7            31.8%   
  19--49 years                     Not At Risk   2,626    2,540    96.7%            86           3.3%    
                                   At Risk       165      90       54.5%            75           45.5%   
  50--64 years                     Not At Risk   1,232    1,080    87.7%            152          12.3%   
                                   At Risk       255      98       38.4%            157          61.6%   
  \<64 years                       Not At Risk   668      194      29.0%            474          71.0%   
                                   At Risk       437      93       21.3%            344          78.7%   

In the high-risk group, the mean age of the vaccinated group was 65.1 years (standard deviation \[SD\] 16.5) compared with 48.2 years (SD 20.4) in the unvaccinated group (p\<0.001). The mean number of risk conditions in the vaccinated group was 1.29 (SD 0.60), compared with 1.15 (SD 0.45) in the unvaccinated group (p\<0.001). In the patients without risk conditions, vaccinated patients were also older than unvaccinated patients (mean 64.6 years \[SD 17.3\] compared with mean 36.6 years \[SD 16.8\], p = 0.003). Vaccinated patients were therefore statistically significantly different from unvaccinated patients, as they were older and had more risk conditions. This should be taken into account when considering outcomes in the different groups.

Resource use in low-risk patients {#sec014}
---------------------------------

[Table 4](#pone.0134928.t004){ref-type="table"} shows the number and cost of ILI-related hospital admissions, GP consultations and outpatient visits in low-risk patients by vaccination and complication status. Data on the absolute numbers of ILI-related admissions, GP consultations and outpatient visits can be found in [S1 Table](#pone.0134928.s002){ref-type="supplementary-material"}, and data on hospital admissions stratified by the route of admission (via accident and emergency, GP referral or other routes) can be found in [S2 Table](#pone.0134928.s003){ref-type="supplementary-material"}.

10.1371/journal.pone.0134928.t004

###### Resource use in low-risk patients.
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                                                                  Vaccinated                    Non-Vaccinated                                                                                                                                                                                                                      
  --------------------------------------------------------------- ----------------------------- ----------------------------- -------------------------- ---------------------------- --------------------------- ----------------------------- ---------------- ------- --------- ------ ----------------------------------------- -------
  **Inpatient Admissions (All)**                                                                                                                                                                                                                                                                                                     
  Had ≥ 1 hospital admission                                      342                           2.0%                          342                        2.0%                         0                           0.0%                          534              0.5%    525       0.4%   9 [\*](#t004fn002){ref-type="table-fn"}   0.0%
  Had ≥ 1 hospital admission (UK)                                 12,404                                                      12,404                                                  0                                                         19,368                   19,041           326                                       
  Mean number of unique admissions (SD)                           1.2 (0.50)                    1.2 (0.50)                    \-                         \-                           1.1 (0.28)                  1.1 (0.28)                    1 (0.0)                                                                             
  Mean length of stay (SD)                                        13.9 (16.7)                   13.9 (16.7)                   \-                         \-                           7.7 (10.6)                  7.8 (10.6)                    3.1 (3.2)                                                                           
  Mean total cost (SD)                                            £3,913,328 (£1,959,010)       £3,913,328 (£1,959,010)       \-                         \-                           £3,102,764 (£1,087,250)     £3,090,087 (£1,068,925)       £19,139 (£0)                                                                        
  Mean total cost (SD) (UK)                                       £141,932,471 (£71, 051,323)   £141,932,471 (£71, 051,323)   \-                         \-                           £112,534,130 (39,433,464)   £112,074,348 (££38,768,835)   ££694,152 (£0)                                                                      
  **GP Surgery Visits**                                                                                                                                                                                                                                                                                                             
  Had ≥ 1 GP surgery visit[\*](#t004fn002){ref-type="table-fn"}   17,482                        100%                          1,334                      7.6%                         16,148                      92.4%                         117,193          100%    6,032     5.1%   111,161                                   94.9%
  Had ≥ 1 GP surgery visit (UK)                                   634,055                                                     48,383                                                  585,672                                                   4,250,472                218,775          4,031,698                                 
  Mean number of GP Surgery visits (SD)                           1.2 (0.46)                    1.9 (0.84)                    1.1 (0.36)                 1.1 (0.38)                   1.9 (0.74)                  1.1 (0.29)                                                                                                        
  Mean (SD) total costs                                           £755,222 (£289,502)           £91,246 (£40,340)             £639,461 (£209,278)        £4,640,843 (£1,603,200)      £412,589 (£160,692)         £4,401,976 (£1,160,521)                                                                                           
  Mean (SD) total costs (UK)                                      £27,391,142 (£10,499,946)     £3,309,401 (£1,463,091)       £23,192,607 (£7,590,303)   £168,318,709 (£58,146,452)   £14,964,188 (£5,828,137)    £159,655,243 (£42,090,930)                                                                                        
  **GP Prescriptions**                                                                                                                                                                                                                                                                                                              
  Had ≥ 1 prescription                                            12,761                        73.0%                         1,103                      6.3%                         11,658                      66.7%                         52,591           44.9%   5,133     4.4%   47,458                                    40.5%
  Had ≥ 1 prescription (UK)                                       462,829                                                     40,005                                                  422,824                                                   1,907,423                186,169          1,721,254                                 
  Mean number of prescriptions obtained (SD)                      3.2 (2.9)                     3.7 (3.3)                     3.2 (2.8)                  1.6 (1.4)                    1.8 (1.4)                   1.6 (1.4)                                                                                                         
  Average cost per script                                         £1.01 (£3.96)                 £1.17 (£4.05)                 £0.98 (£3.95)              £0.61 (£2.26)                £0.63 (£2.01)               £0.60 (£2.29)                                                                                                     
  **Out Patient Clinic Care **                                                                                                                                                                                                                                                                                                      
  Had ≥ 1 OP Clinic visit                                         91                            0.5%                          31                         0.2%                         60                          0.3%                          303              0.3%    90        0.1%   213                                       0.2%
  Had ≥ 1 OP Clinic visit (UK)                                    3,300                                                       1,124                                                   2,176                                                     10,990                   3,264            7,725                                     
  Mean number of OP clinic visit(SD)                              1.0 (0.21)                    1.1 (0.25)                    1.0 (0.28)                 1.1 (0.27)                   1.1 (0.25)                  1.1 (0.27)                                                                                                        
  Mean (SD) total costs                                           £13,377 (£2,809)              £5,013 (£1,139)               £8,820 (£2,470)            £48,995 (£12,026)            £14,553 (£3,308)            £34,442 (£8,454)                                                                                                  
  Mean (SD) total costs (UK)                                      £485,170 (££101,880)          £181,816 (£41,310)            £319,893 (£89,584)         £1,776,999 (£436,171)        £527,823 (£119,978)         £1,249,177 (£306,618)                                                                                             

GP, general practitioner; OP, outpatient; SD, standard deviation; UK, extrapolated to UK population

\*Review of the records indicated that these patients had been mis-coded and had complications

In low-risk patients, unvaccinated patients used more GP and outpatient resources than vaccinated patients, reflecting the large number of unvaccinated low-risk cases in the database. Secondary care resource use was more evenly split, with slightly higher total resource use and cost in the group of vaccinated patients than in the group of unvaccinated patients. This is consistent with the older age of vaccinated patients compared with the unvaccinated group. Extrapolated to the UK, the cost of ILI-related GP visits and hospital admissions over the study period in low-risk vaccinated patients was £27,391,142 and £141,932,471, respectively. In low-risk unvaccinated patients the corresponding values were £168,318,709 and £112,534,130, respectively.

Secondary care resource use was concentrated in cases of influenza with complications recorded, regardless of vaccination status.

Resource use in high-risk patients {#sec015}
----------------------------------

[Table 5](#pone.0134928.t005){ref-type="table"} shows the number and cost of ILI-related hospital admissions, GP consultations and outpatient visits in high-risk patients by vaccination and complication status. Data on the absolute numbers of ILI-related admissions, GP consultations and outpatient visits can be found in [S1 Table](#pone.0134928.s002){ref-type="supplementary-material"}, and data on hospital admissions stratified by the route of admission (via accident and emergency, GP referral or other routes) can be found in [S3 Table](#pone.0134928.s004){ref-type="supplementary-material"}.

10.1371/journal.pone.0134928.t005

###### Resource use in high-risk patients.
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                                               Vaccinated                   Non-Vaccinated                                                                                                                                                                                                                
  -------------------------------------------- ---------------------------- ---------------------------- -------------------------- -------------------------- --------------------------- --------------------------- --------------- ------- -------- ------- ----------------------------------------- -------
  **Inpatient Admissions (All)**                                                                                                                                                                                                                                                                           
  Had ≥ 1 hospital admission                   503                          4.0%                         503                        4.0%                       0                           0.0%                        222             2.5%    219      2.4%    3 [\*](#t005fn002){ref-type="table-fn"}   0.0%
  Had ≥ 1 hospital admission (UK)              18,243                                                    18,243                                                0                                                       8,052                   7,943            109                                       
  Mean number of unique admissions (SD)        1.2 (0.53)                   1.2 (0.53)                   \-                         \-                         1.2 (0.51)                  1.2 (0.51)                  1 (0.0)                                                                            
  Mean length of stay (SD)                     12.9 (5.9)                   12.9 (5.9)                   \-                         \-                         12.4 (19.5)                 12.6 (19.6)                 4 (3.6)                                                                            
  Mean total cost (SD)                         £5,341,498 (£1,078,996)      £5,341,498 (£1,078,996)      \-                         \-                         £2,266,105 (£1,514,544)     £2,271,538 (£1,501,739)     £8,232 (£0)                                                                        
  Mean total cost (SD) (UK)                    £193,730,761 (£39,134,100)   £193,730,761 (£39,134,100)   \-                         \-                         £82,189,349 (£54,930,988)   £82,386,399 (£54,466,563)   £298,566 (£0)                                                                      
  **GP Surgery Visits**                                                                                                                                                                                                                                                                                   
  Had ≥ 1 GP surgery visit                     12,514                       100%                         1,807                      14.4%                      10,707                      85.6%                       9,004           100%    1,225    13.6%   7,779                                     86.4%
  Had ≥ 1 GP surgery visit (UK)                453,870                                                   65,538                                                388,332                                                 326,566                 44,430           282,137                                   
  Mean number of GP Surgery visits (SD)        1.3 (0.65)                   1.9 (1.0)                    1.2 (0.49)                 1.3 (0.62)                 1.8 (0.98)                  1.2 (0.49)                                                                                                     
  Mean (SD) total costs                        £585,655 (£292,828)          £123,599 (£65,052)           £462,542 (£188,871)        £421,387 (£200,969)        £79,380 (£43,218)           £336,053 (£137,222)                                                                                            
  Mean (SD) total costs (UK)                   £21,241,118 (£10,620,577)    £4,482,811 (£2,359,371)      £16,775,933 (£6,850,161)   £15,283,283 (£7,288,944)   £2,879,033 (£1,567,473)     £12,188,304 (£4,976,904)                                                                                       
  **GP Prescriptions**                                                                                                                                                                                                                                                                                    
  Had ≥ 1 prescription                         10,454                       83.5%                        1,454                      11.6%                      9,000                       71.9%                       6,398           71.1%   985      10.9%   5,413                                     60.1%
  Had ≥ 1 prescription (UK)                    379,156                                                   52,735                                                326,421                                                 232,049                 35,725           196,324                                   
  Mean number of prescriptions obtained (SD)   5.6 (5.1)                    6.1 (6.1)                    5.5 (4.9)                  3.6 (3.9)                  3.6 (4.1)                   3.6 (3.9)                                                                                                      
  Average cost per script                      £1.28 (£4.50)                £1.95 (£5.64)                £1.13 (£4.18)              £1.19 (£4.33)              £1.47 (£4.53)               £1.12 (£4.27)                                                                                                  
  **Out Patient Clinic Care **                                                                                                                                                                                                                                                                            
  Had ≥ 1 OP Clinic visit                      106                          0.8%                         42                         0.3%                       64                          0.5%                        74              0.8%    29       0.3%    45                                        0.5%
  Had ≥ 1 OP Clinic visit (UK)                 3,845                                                     1,523                                                 2,321                                                   2,684                   1,052            1,632                                     
  Mean number of OP clinic visit(SD)           1.1 (0.31)                   1.1 (0.33)                   1.1 (0.29)                 1.1 (0.7)                  1.0 (0.0)                   1.2 (0.91)                                                                                                     
  Mean (SD) total costs                        £17,140 (£4,830)             £6,791 (£2,037)              £10,349 (£2,728)           £11,966 (£7,615)           £4,263 (£0)                 £7,938 (£6,020)                                                                                                
  Mean (SD) total costs (UK)                   £621,651 (£175,179)          £246,303 (£73,880)           £375,348 (£98,942)         £433,995 (£276,188)        £154,615 (£0)               £287,903 (£218,339)                                                                                            

GP, general practitioner; OP, outpatient; SD, standard deviation; UK, extrapolated to UK population

\*Review of the records indicated that these patients had been mis-coded and had complications

In high-risk patients, the group of vaccinated patients used more resources in primary and secondary care, compared with the group of unvaccinated patients. This is consistent with the older age and higher number of risk conditions in vaccinated than unvaccinated patients. As was the case in low-risk patients, secondary care resource use was concentrated in cases of influenza with complications recorded, regardless of vaccination status. Extrapolated to the UK, the cost of ILI-related GP visits and hospital admissions over the study period in high-risk vaccinated patients was £21,241,118 and £193,730,761, respectively. In high-risk unvaccinated patients the corresponding values were £15,283,283 and £82,189,349, respectively.

Mortality {#sec016}
---------

[Table 6](#pone.0134928.t006){ref-type="table"} shows the number of ILI-related deaths by vaccination status. Overall, more deaths were observed in vaccinated than unvaccinated patients. This is consistent with the systematic difference between vaccinated and unvaccinated individuals, as vaccinated individuals were older and more fragile with more risk conditions than unvaccinated individuals. However, among the group aged 65 years or more, the mortality rate among vaccinated individuals was 25% (odds ratio \[OR\] 0.75; 95% confidence interval \[CI\] 0.65 to 0.88; p\<0.001) lower than in unvaccinated individuals (3.3% of the age category and 4.3% of the age category, respectively) ([Table 6](#pone.0134928.t006){ref-type="table"}).

10.1371/journal.pone.0134928.t006

###### Mortality by vaccination status and age.
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  Parameter           All         Influenza without complications recorded   Influenza with complications recorded                                                       
  ------------------- ----------- ------------------------------------------ --------------------------------------- ------------- -------- ------ ------------- ------- -------
  **Vaccinated**                                                                                                                                                         
  All Patients        29,996      633                                        2.1%                                    26,855        434      1.6%   3,141         199     6.3%
  All Patients (UK)   1,087,925   22,958                                                                             974,004       15,741          113,921       7,218   
  Mean Age (SD)       64.8                                                                                           64.5 (16.9)                   67.1 (17.4)           
  Age Categories                                                                                                                                                         
  \<5                 23          0                                          0.0%                                    20            0        0.0%   3             0       0.0%
  5--18               537         1                                          0.2%                                    481           1        0.2%   56            0       0.0%
  19--49              4,571       16                                         0.4%                                    4,153         16       0.4%   418           0       0.0%
  50--64              7,086       32                                         0.5%                                    6,456         19       0.3%   630           13      2.1%
  65+                 17,779      584                                        3.3%                                    15,745        398      2.5%   2,034         186     9.1%
  **Unvaccinated**                                                                                                                                                       
  All Patients        126,197     549                                        0.4%                                    118940        456      0.4%   7,257         93      1.3%
  All Patients (UK)   4,577,038   19,912                                                                             4,313,834     16,539          263,204       3,373   
  Mean Age (SD)       37.5                                                                                           37.4 (17.2)                   39.3 (19.3)           
  Age Categories                                                                                                                                                         
  \<5                 2,822       9                                          0.3%                                    2,585         9        0.3%   237           0       0.0%
  5--18               16,704      28                                         0.2%                                    15,827        28       0.2%   877           0       0.0%
  19--49              74,335      184                                        0.2%                                    70,327        177      0.3%   4,008         7       0.2%
  50--64              26,461      74                                         0.3%                                    24,934        62       0.2%   1,527         12      0.8%
  65+                 5,875       254                                        4.3%                                    5,267         180      3.4%   608           74      12.2%

SD, standard deviation; UK, extrapolated to UK population

Mismatch analysis {#sec017}
-----------------

[Table 7](#pone.0134928.t007){ref-type="table"} shows the circulating virus strains, influenza B vaccine lineages, and the degree of matching between the vaccine and the circulating B lineage in each year of the study, from HPA data. There was a mismatch between the vaccine and circulating influenza B virus lineage in five of the ten years, and the two influenza B lineages co-circulated in three of the ten years.

10.1371/journal.pone.0134928.t007

###### Mismatch between vaccine lineages and circulating influenza B lineages (HPA data).
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               Distribution A & B   Vaccine lineage   Distribution within B   Matching within B          
  ------------ -------------------- ----------------- ----------------------- ------------------- ------ ------
  2000--2001   37%                  63%               Yamagata                0%                  100%   100%
  2001--2002   97%                  3%                Yamagata                0%                  100%   100%
  2002--2003   51%                  49%               Victoria                100%                0%     100%
  2003--2004   99.6%                0%                Victoria                0%                  100%   0%
  2004--2005   85%                  15%               Yamagata                17%                 83%    83%
  2005--2006   30%                  70%               Yamagata                99%                 1%     1%
  2006--2007   99%                  1%                Victoria                33%                 67%    33%
  2007--2008   64%                  36%               Victoria                0%                  100%   0%
  2008--2009   90%                  10%               Yamagata                94%                 6%     6%
  2009--2010   99%                  1%                Victoria                100%                0%     100%
  Average      75%                  25%                                       44%                 56%    52%

The season 2005--2006 also had a very high circulation of influenza B, with influenza B accounting for 70% of the circulating influenza that season.

There was a trend for influenza B mismatched seasons to be associated with peaks in ILI-related GP visits ([Fig 1A](#pone.0134928.g001){ref-type="fig"}). The season with highest mismatch and highest influenza B circulation, 2005--2006, was clearly associated with a peak in ILI-related GP visits ([Fig 1A](#pone.0134928.g001){ref-type="fig"}). The highest rate of ILI-related deaths occurred in 2007--2008 and the second highest in 2005--2006, both influenza B mismatched seasons ([Fig 1B](#pone.0134928.g001){ref-type="fig"}). ILI-related hospital admissions showed a similar pattern ([Fig 1C](#pone.0134928.g001){ref-type="fig"}).

![Number of (A) GP visits, (B) deaths and (C) hospitalisations by influenza week and pathogen.\
'Flu week' indicates the year (first four digits) and range of weeks (last four digits), e.g. '20024044' = 2002, weeks 40--44. GP, general practitioner.](pone.0134928.g001){#pone.0134928.g001}

Hospital admissions were highly correlated with GP visits (correlation coefficient 0.893 for influenza A, 0.789 for influenza B and 0.715 for others), and mortality was highly correlated with hospitalisation (correlation coefficient 0.884 for influenza B, 0.870 for influenza A, and 0.632 for others).

Multivariate analysis {#sec018}
---------------------

[Table 8](#pone.0134928.t008){ref-type="table"} shows the logistic regression coefficients for the likelihood of \>1 GP visit, hospital admission and mortality. High-risk patients and patients who had been vaccinated had a higher probability of \>1 ILI-related GP visit, compared with those who were not high-risk or had not been vaccinated. The OR for vaccinated patients was 1.19 (95% CI 1.11 to 1.28; p\<0.001) and the OR for high-risk patients was 2.16 (95% CI 2.02 to 2.28; p\<0.001). However, there was an interaction such that patients who were high-risk and vaccinated had a reduced risk of \>1 GP visit, with an OR of 0.82 (95% CI 0.75 to 0.91; p\<0.001). There was no apparent age interaction, so these effects were relevant for all age groups.

10.1371/journal.pone.0134928.t008

###### Logistic regression coefficients for the risk of \>1 general practitioner visit, hospitalisation and mortality.

![](pone.0134928.t008){#pone.0134928.t008g}

  All ages                                                                   Coefficient             SE      t value   Pr(*\>\|*t\|)
  -------------------------------------------------------------------------- ----------------------- ------- --------- ---------------
  **Likelihood of \>1 GP visit in the 3 months after influenza diagnosis**                                             
  (Intercept)                                                                -2.280                  0.078   -29.190   0.000
  Age *≤* 1 year                                                             -0.233                  0.085   -2.730    0.006
  Age 2--4 years                                                             -0.315                  0.078   -4.040    0.000
  Age 5--18 years                                                            -0.090                  0.076   -1.180    0.238
  Age 19--49 years                                                           *Reference age group*                     
  Age 50--64 years                                                           0.193                   0.083   2.340     0.020
  Age *≥* 65 years                                                           0.063                   0.083   0.750     0.451
  Female                                                                     0.144                   0.020   7.340     0.000
  Manifested influenza                                                       0.241                   0.066   3.640     0.000
  Hospital Event                                                             1.262                   0.063   20.010    0.000
  High risk patient                                                          0.764                   0.031   24.570    0.000
  Vaccinated                                                                 0.177                   0.036   4.990     0.000
  High risk & Vaccinated                                                     -0.193                  0.048   -4.030    0.000
  %Adenovirus                                                                0.386                   0.057   6.740     0.000
  %Parainfluenza                                                             0.732                   0.139   5.280     0.000
  \% influenza B                                                             -0.302                  0.082   -3.690    0.000
  %Coronavirus                                                               -2.808                  1.001   -2.810    0.005
  High risk & Vaccinated                                                     -0.252                  0.050   -5.030    0.000
  **Likelihood of hospital admission during the study period**                                                         
  (Intercept)                                                                -6.158                  0.107   -57.680   0.000
  Age *≤* 1 year                                                             2.199                   0.425   5.180     0.000
  Age 2--4 years                                                             1.799                   0.201   8.930     0.000
  Age 5--18 years                                                            0.331                   0.152   2.180     0.029
  Age 19--49 years                                                           *Reference age group*                     
  Age 50--64 years                                                           0.699                   0.102   6.850     0.000
  Age *≥* 65 years                                                           1.903                   0.108   17.600    0.000
  Female                                                                     -0.307                  0.060   -5.140    0.000
  Manifested influenza                                                       1..2276                 0.103   11.900    0.000
  Vaccine B mismatch                                                         0.186                   0.058   3.200     0.001
  High-risk                                                                  1.174                   0.096   12.250    0.000
  Vaccinated                                                                 0.613                   0.100   6.110     0.000
  High-risk & Vaccinated                                                     -0.533                  0.128   -4.160    0.000
  \% adenovirus                                                              0.816                   0.166   4.920     0.000
  \% parainfluenza                                                           1.517                   0.361   4.200     0.000
  **Likelihood of death during the study period**                                                                      
  (Intercept)                                                                -5.094                  0.392   -13.000   0.000
  Age *≤* 1 year                                                             -1.096                  0.495   -2.210    0.027
  Age 2--4 years                                                             -0.497                  0.392   -1.270    0.204
  Age 5--18 years                                                            -0.318                  0.394   -0.810    0.419
  Age 19--49 years                                                           *Reference age group*                     
  Age 50--64 years                                                           1.310                   0.397   3.300     0.001
  Age *≥* 65 years                                                           2.822                   0.389   7.250     0.000
  Female                                                                     -0.200                  0.070   -2.870    0.004
  Manifested                                                                 1.234                   0.107   11.540    0.000
  High-risk                                                                  0.376                   0.077   4.910     0.000
  Vaccinated                                                                 -0.246                  0.084   -2.940    0.003
  Complications                                                              0.970                   0.083   11.690    0.000
  \% influenza A                                                             -0.841                  0.177   -4.750    0.000
  \% RSV                                                                     -1.051                  0.214   -4.910    0.000

GP, general practitioner; RSV, respiratory syncytial virus, SE, standard error

High-risk individuals who were also vaccinated had a lower probability of ILI-related hospitalisation than individuals who were high-risk or vaccinated alone (OR = 0.59; 95% CI 0.46 to 0.75; p\<0.001). In years with influenza B mismatch, there was a statistically significant increase in the odds of hospital admission (OR = 1.2; 95% CI 1.07 to 1.35; p\<0.001). Patients who were high-risk had a higher probability of ILI-related death during the study period (OR = 1.46; 95% CI 1.25 to 1.69; p\<0.001), and patients who were vaccinated had a lower probability of death during the study period (OR = 0.78; 95% CI 0.66 to 0.92; p\<0.01).

Discussion {#sec019}
==========

The present study builds on previous investigations of the burden of ILI in the UK \[[@pone.0134928.ref007],[@pone.0134928.ref008]\] in several ways. To our knowledge, this is the first time that linked primary care and hospital databases have been used to estimate the burden of ILI. Furthermore, this is the first study to report quantitative data for ILI burden by complication status (with complications recorded or without complications recorded), age, risk and vaccination status.

Influenza vaccination uptake increased over the study period, but vaccination still failed to reach 20--25% of people aged 65 years and older. In England, the target rate for influenza vaccination in 2011--2012 was 75% in people aged 65+ years and 60% in other at-risk groups, increasing to 75% in 2013/2014 \[[@pone.0134928.ref020]\]. Our study indicates that the vaccination uptake rates achieved in the elderly population were close to the target range. However, vaccination uptake rates in other at-risk groups were generally exceedingly low compared with the 2013/2014 target of 75%, except in a few conditions such as diabetes and renal disease. Improving vaccination uptake rates in younger age groups with risk conditions, and further improving vaccination uptake in the elderly, may have the potential to reduce the considerable burden of ILI in the UK. Our analysis demonstrates that vaccinated high-risk individuals have better outcomes than high-risk unvaccinated individuals.

Most ILI cases occurred in individuals who were not categorised as high-risk, and who were not vaccinated. Over 117,000 such patients visited a GP and 534 were admitted to hospital in the study population, at an estimated cost of over £4 million and over £3 million, respectively. Scaled up to the whole UK population, this would be equivalent to over £168 million for GP visits and over £112 million for hospital admissions. This raises the possibility that mass annual vaccination could potentially have medical and economic benefits, by reducing the burden of influenza cases in individuals who are not in groups currently targeted for vaccination. Universal influenza vaccination was introduced in Ontario, Canada, in 2000 and has been associated with reductions in influenza-related mortality and healthcare use, compared with targeted vaccination programmes in other provinces \[[@pone.0134928.ref021]\]. It has been suggested that mass vaccination could be cost-saving in the USA \[[@pone.0134928.ref022]\].

Vaccinated patients differed significantly from unvaccinated patients, being older and with more risk conditions. This pattern is well known \[[@pone.0134928.ref023]\], and is to be expected from current government policy, which targets elderly and/or high-risk groups for influenza vaccination. It is consistent with the observed pattern of higher resource use in vaccinated patients in the high-risk group in the present study; since vaccinated individuals were older and had more risk conditions than unvaccinated individuals, they are likely to have more fragile health and thus to need more healthcare. As vaccinated and unvaccinated groups are significantly different, outcomes cannot be directly compared and the data should be interpreted with caution. The only population in which vaccinated and unvaccinated groups could be compared is the sub-group aged 65 years and older, as according to current policy all individuals in this age group should receive seasonal influenza vaccination. Among this group, the ILI-related mortality rate among vaccinated individuals was 25% lower than the mortality rate among unvaccinated individuals. This is consistent with a protective effect of influenza vaccination. The effect size was similar to that reported by previous studies in this population group, which have reported reductions of 33--62% in hospitalisations, 27--39% in hospitalisations for acute and chronic respiratory illness and 39--54 in all-cause mortality \[[@pone.0134928.ref024]--[@pone.0134928.ref026]\].

Multivariate analysis indicated that patients categorised as high-risk had a disproportionate risk of hospitalisation. However, high-risk individuals who had also been vaccinated had a lower risk of hospitalisation than individuals who were high-risk alone. Similarly, patients who were high-risk had a higher probability of \>1 GP visit, whereas patients who were high-risk and vaccinated had a lower probability of \>1 GP visit. These findings suggest that vaccination may help to reduce the risk of hospitalisation and additional GP visits in high-risk groups. This demonstrates the clear benefit of vaccination of high-risk individuals and the rationale for ensuring that coverage in this group of individuals be reinforced, as coverage in those younger than 65 years is below target. Low vaccination coverage places individuals at risk of serious complications and death because they are not being vaccinated against influenza. However, although our results show clearly that vaccinated high-risk patients in the database had lower rates of additional GP visits and hospitalisations than unvaccinated high-risk patients in the database, there may be potential for confounding by differences in health-seeking behaviour that could not be captured in the database or accounted for in the analysis. For example, surveys in adults with asthma \[[@pone.0134928.ref027]\] and parents of high-risk children \[[@pone.0134928.ref028]\] at single UK GP practices have identified lack of awareness, barriers to access and health beliefs as factors influencing influenza vaccine uptake. Such factors could have the potential to confound our results if they also affect patients' readiness to seek treatment (for example, patients who wait until severe symptoms develop before presenting for medical attention may require higher levels of intervention than patients who present early). Our analysis would not be able to identify such potential confounding factors, and this is a limitation of the study. A recent case-control study using GPRD data in people at low risk for influenza in the UK found that influenza vaccination reduced the risk of influenza (OR 0.74, 95% CI 0.60, 0.91) when given within 4 months before seasonal influenza outbreaks \[[@pone.0134928.ref029]\]. However, despite the authors' attempt to minimise confounding, they identified a residual confounding effect in that a group of people in the study with annual vaccinations in multiple years were also consistently more likely to develop influenza than those who received fewer annual vaccinations \[[@pone.0134928.ref029]\]. This may indicate that this group had predisposing medical conditions that made them simultaneously more likely to seek influenza vaccination and also at higher risk of influenza.

As per our assumption that the circulation data from the HPA was reflective of the strain circulation in the community, which is a limitation of our study, influenza B GP visits, hospitalisations and deaths showed peaks in influenza seasons with high influenza B activity and vaccine mismatch. The correlation coefficients show that for influenza B, deaths were more closely correlated with hospitalisations than hospitalisations with GP visits. For influenza A and other respiratory infections, hospitalisations were more closely correlated with GP visits than deaths with hospitalisation. The multivariate analysis also showed a statistically significant increase in the odds of hospitalisation in years with vaccine influenza B mismatch. In seasons with a mismatch between the vaccine lineage and the circulating influenza lineages, individuals may receive less clinical benefit from vaccination than anticipated, because the vaccine provides limited or no protection against the mismatched virus lineage. This suggests that improving vaccine protection against influenza B in mismatched years could be of value. Quadrivalent influenza vaccination provides protection against both influenza B lineages, which have started to co-circulate in recent years, and should therefore improve protection.

It should be noted that the mismatch analysis depends on an implicit assumption that the HPA surveillance data are representative of cases of respiratory infection seen in GP practices and hospitals nationally. However, the HPA data are derived from sentinel practices, which may differ from the more general pool of GP practices from which the GPRD data are derived. It is possible that using the HPA data to attribute cases between the various respiratory viruses could over- or under-estimate the proportion of infections due to each pathogen, and this is a limitation of the study.

A further limitation of the study is that complication status was assessed according to whether complications were recorded in the database. If any patients had complications that were not recorded, they could potentially have been mis-coded as having influenza without complications. To explore this possibility we investigated the full records of the small number of patients who were admitted to hospital despite having no complications of influenza recorded in the database. This showed that although the patients had no secondary diagnosis codes (and were therefore classed as having no complications), they in fact had complications such as pneumonia or other respiratory manifestations. Coding errors such as these form a natural limitation to any retrospective database study, as even a comprehensive database cannot capture all possible information.

Our data are likely to underestimate the true burden of ILI in the UK, because the years included in the study all happened to be years of low influenza activity, as presented in the primary publication (Watkins et al., in preparation). Our data would also not have identified hospital-acquired influenza infections. Furthermore, previous research has indicated that hospitalisation for influenza may be a trigger for long-term health decline in elderly patients \[[@pone.0134928.ref030]\]. Our study has not attempted to take such effects into account.

This study provides the most detailed quantitative data to date on the ILI burden in the UK. It should help to narrow the considerable uncertainties in modelling the potential impact of interventions \[[@pone.0134928.ref010]\].

Conclusions {#sec020}
===========

Our results indicate that although vaccination rates in target groups have increased over the study period, a substantial proportion of people are still not receiving influenza vaccination. Improving the uptake of influenza vaccination among elderly people and other high-risk groups has the potential to achieve substantial health benefits.
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